Diisopropylethylamine → 2-{[(S)-((Z)-4-tert-butoxycarbonylamino-but-2-enyl)-5,6,7,8-tetrahydro-quinolin-8-yl-amino]-methyl}-benzimidazole-1-carboxylic acid tert-butyl ester

HRID 899635ノート

反応式

HRID 899635 の反応式
[C:1]([O:5][C:6](=[O:13])[NH:7][CH2:8][CH:9]=[CH:10][CH2:11]Cl)([CH3:4])([CH3:3])[CH3:2].C(N(C(C)C)CC)(C)C.[C:23]([O:27][C:28]([N:30]1[C:34]2[CH:35]=[CH:36][CH:37]=[CH:38][C:33]=2[N:32]=[C:31]1[CH2:39][NH:40][CH:41]1[C:50]2[N:49]=[CH:48][CH:47]=[CH:46][C:45]=2[CH2:44][CH2:43][CH2:42]1)=[O:29])([CH3:26])([CH3:25])[CH3:24]>C(#N)C.[I-].[K+]>[C:23]([O:27][C:28]([N:30]1[C:34]2[CH:35]=[CH:36][CH:37]=[CH:38][C:33]=2[N:32]=[C:31]1[CH2:39][N:40]([CH2:11]/[CH:10]=[CH:9]\[CH2:8][NH:7][C:6]([O:5][C:1]([CH3:2])([CH3:4])[CH3:3])=[O:13])[C@@H:41]1[C:50]2[N:49]=[CH:48][CH:47]=[CH:46][C:45]=2[CH2:44][CH2:43][CH2:42]1)=[O:29])([CH3:26])([CH3:24])[CH3:25]

参加物

6

反応物 3

HCID 81531DiisopropylethylamineHCID 219850812-[(5,6,7,8-Tetrahydroquinolin-8-ylamino)-methyl]-benzimidazole-1-carboxylic acid tert-butyl esterHCID 71438464(4-Chloro-but-2-enyl)-carbamic acid tert-butyl ester

生成物 1

HCID 692939962-{[(S)-((Z)-4-tert-butoxycarbonylamino-but-2-enyl)-5,6,7,8-tetrahydro-quinolin-8-yl-amino]-methyl}-benzimidazole-1-carboxylic acid tert-butyl ester収率 161.1%

試薬・触媒・溶媒 2

HCID 4875Potassium Iodide触媒HCID 6342Acetonitrile溶媒

反応条件

温度
60 °C

実験手順

(4-Chloro-but-2-enyl)-carbamic acid tert-butyl ester (1.81 g, 7.47 mmol), potassium iodide (59 mg, 0.36 mmol) and diisopropylethylamine (1.80 mL, 10.3 mmol) were added to a solution of 2-[(5,6,7,8-tetrahydroquinolin-8-ylamino)-methyl]-benzimidazole-1-carboxylic acid tert-butyl ester (2.57 g, 6.79 mmol)) in acetonitrile (70 mL) and warmed to 60° C. and stirred for 17 h under nitrogen. The solvent was removed in vacuo. The residue was dissolved in methylene chloride (100 mL) and washed with brine (100 mL). The aqueous layer was extracted with methylene chloride (2×150 mL). The combined organic layers were dried (Na2SO4) and concentrated. The crude mixture was purified by column chromatography on silica gel (150 g) to afford 2-{[(S)-((Z)-4-tert-butoxycarbonylamino-but-2-enyl)-5,6,7,8-tetrahydro-quinolin-8-yl-amino]-methyl}-benzimidazole-1-carboxylic acid tert-butyl ester (5.99 g, 88%) as a white foamy solid. 1H NMR (CDCl3) δ 1.43 (s, 9H), 1.72 (s, 9H), 1.95-2.08 (m, 4H), 2.09-2.20 (m, 1H), 2.61 (d, 1H, J=16.2 Hz), 3.28 (dd, 1H, J=14.1, 5.4 Hz), 3.62 (dd, 1H, J=13.7, 7.2 Hz), 3.69-3.85 (m, 2H), 4.29 (dd, 1H, J=9.2, 6.6 Hz), 4.42 (d, 1H, J=14.9 Hz), 4.48 (d, 1H, J=14.9 Hz), 5.43-5.63 (m, 2H), 6.19 (s, 1H), 6.87 (dd, 1H, J=7.5, 4.8 Hz), 7.17 (d, 1H, J=7.7 Hz), 7.23-7.28 (m, 1H), 7.65-7.71 (m, 1H), 7.75-7.80 (m, 1H), 8.34 (d, 1H, J=4.4 Hz).

後処理

  1. customThe solvent was removed in vacuo
  2. dissolutionThe residue was dissolved in methylene chloride (100 mL)
  3. washwashed with brine (100 mL)
  4. extractionThe aqueous layer was extracted with methylene chloride (2×150 mL)
  5. dry with materialThe combined organic layers were dried (Na2SO4)
  6. concentrationconcentrated
  7. customThe crude mixture was purified by column chromatography on silica gel (150 g)

出典と根拠

ORDレコード
ord-a554f619084747708fc8575284fb085a
出典データセット
uspto-grants-2008_04
特許番号
US07354932B2

反応ノート

読み込み中…